CAR-T Promise for Patients with Solid Tumors

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

ADVERTISEMENT

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

French Biotech Develops a New Generation of Safer CAR-T Cells

Interview 13 Jun 2018

CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead

Belgian Biotech Gets a €46M Boost to Keep up in the CAR-T Race

Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV

The First CAR-T Therapy Is Not Living Up to Commercial Expectations

“This is the First Time CAR-T Has Ever Worked on Acute Myeloid Leukemia“

French CAR-T Developer Raises $164M Despite a Challenging Road